Baldwin Brothers LLC Axsome Therapeutics, Inc. Transaction History

Baldwin Brothers LLC

$1.38 Billion
Q2 2025

A detailed history of Baldwin Brothers LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Baldwin Brothers LLC holds 48,570 shares of AXSM stock, worth $5.09 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

48,570

Previous 49,570 2.02%

Holding current value

$5.09 Million

Previous $5.88 Million 13.7%

% of portfolio

0.37%

Previous 0.44%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	SELL	$95.65 - $116.49 $95,650 - $116,490	-1,000 Reduced 2.02%	48,570 $5.07 Million
Q4 2024 Jan 22, 2025	SELL	$83.08 - $100.49 $10,385 - $12,561	-125 Reduced 0.25%	49,570 $4.19 Million
Q1 2024 Apr 12, 2024	BUY	$69.39 - $97.64 $48,573 - $68,348	700 Added 1.43%	49,695 $3.97 Million
Q4 2023 Jan 08, 2024	BUY	$57.42 - $83.61 $57,420 - $83,610	1,000 Added 2.08%	48,995 $3.9 Million
Q2 2023 Jul 14, 2023	BUY	$58.41 - $90.35 $29,205 - $45,175	500 Added 1.05%	47,995 $3.45 Million
Q4 2022 Jan 27, 2023	SELL	$39.94 - $79.72 $213,679 - $426,502	-5,350 Reduced 10.12%	47,495 $0
Q2 2022 Jul 18, 2022	SELL	$21.74 - $46.75 $43,480 - $93,500	-2,000 Reduced 3.65%	52,845 $2.02 Million
Q1 2022 Apr 13, 2022	BUY	$23.7 - $41.39 $308,100 - $538,070	13,000 Added 31.07%	54,845 $2.27 Million
Q3 2021 Oct 27, 2021	BUY	$19.91 - $68.26 $338,470 - $1.16 Million	17,000 Added 68.42%	41,845 $1.38 Million
Q1 2021 Apr 08, 2021	SELL	$55.91 - $81.44 $27,955 - $40,720	-500 Reduced 1.97%	24,845 $1.41 Million
Q4 2020 Jan 12, 2021	BUY	$66.31 - $86.52 $33,155 - $43,260	500 Added 2.01%	25,345 $2.07 Million
Q1 2020 Apr 15, 2020	SELL	$41.2 - $101.31 $428,315 - $1.05 Million	-10,396 Reduced 29.5%	24,845 $1.46 Million
Q4 2019 Jan 29, 2020	BUY	$16.71 - $106.24 $91,905 - $584,320	5,500 Added 18.49%	35,241 $3.64 Million
Q3 2019 Oct 10, 2019	BUY	$20.24 - $29.16 $10,120 - $14,580	500 Added 1.71%	29,741 $602,000
Q4 2018 Feb 01, 2019	SELL	$2.0 - $4.15 $2,620 - $5,436	-1,310 Reduced 4.29%	29,241 $82,000
Q3 2018 Oct 26, 2018	BUY	$2.3 - $3.55 $11,500 - $17,750	5,000 Added 19.57%	30,551 $105,000
Q2 2018 Jul 24, 2018	BUY	$2.15 - $3.6 $12,900 - $21,600	6,000 Added 30.69%	25,551 $82,000
Q3 2017 Oct 26, 2017	BUY	$4.65 - $6.1 $90,912 - $119,261	19,551	19,551 $109,000

Others Institutions Holding AXSM

# of Institutions

404

Shares Held

36.5M

Call Options Held

751K

Put Options Held

568K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.49B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldwin Brothers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldwin Brothers LLC with notifications on news.

Account

Baldwin Brothers LLC Axsome Therapeutics, Inc. Transaction History